This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
Biomarker Research Open Access 09 October 2021
-
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study
Critical Care Open Access 09 December 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. BMS bets on targeting IL-8 to enhance cancer immunotherapies. Nat Biotechnol 34, 1006–1007 (2016). https://doi.org/10.1038/nbt1016-1006
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1016-1006
This article is cited by
-
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
Biomarker Research (2021)
-
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study
Critical Care (2019)